180 related articles for article (PubMed ID: 37945816)
1. Investigation of GPR143 as a promising novel marker for the progression of skin cutaneous melanoma through bioinformatic analyses and cell experiments.
Bai R; Yin P; Xing Z; Wu S; Zhang W; Ma X; Gan X; Liang Y; Zang Q; Lei H; Wei Y; Zhang C; Dai B; Zheng Y
Apoptosis; 2024 Apr; 29(3-4):372-392. PubMed ID: 37945816
[TBL] [Abstract][Full Text] [Related]
2. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma.
Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G
Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266
[TBL] [Abstract][Full Text] [Related]
3. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
Fan Y; Liang X; Yu D
Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
[TBL] [Abstract][Full Text] [Related]
4. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
[TBL] [Abstract][Full Text] [Related]
5. TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment.
Zhu X; Zeng Z; Chen M; Chen X; Hu D; Jiang W; Du M; Chen T; Chen T; Liao W; Zhang C; Qu Y; Pan W
Dis Markers; 2023; 2023():8101837. PubMed ID: 36741909
[TBL] [Abstract][Full Text] [Related]
6. Expression profile and prognostic values of LSM family in skin cutaneous melanoma.
Sun X; Zhang J; Xiao C; Ge Z
BMC Med Genomics; 2022 Nov; 15(1):238. PubMed ID: 36371223
[TBL] [Abstract][Full Text] [Related]
7. Combined signature of G protein-coupled receptors and tumor microenvironment provides a prognostic and therapeutic biomarker for skin cutaneous melanoma.
Song B; Wang K; Peng Y; Zhu Y; Cui Z; Chen L; Yu Z; Song B
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18135-18160. PubMed ID: 38006451
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
Jiang Y; Zhang C; Zhang J; Han D; Shi X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
[TBL] [Abstract][Full Text] [Related]
9. A Potential Diagnostic and Prognostic Biomarker TMEM176B and Its Relationship With Immune Infiltration in Skin Cutaneous Melanoma.
Jiang L; Yang Y; Liu F; Ma M; Gao J; Sun L; Chen Y; Shen Z; Wu D
Front Cell Dev Biol; 2022; 10():859958. PubMed ID: 35399535
[No Abstract] [Full Text] [Related]
10. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
Zhao S; Zhu Y; Liu H; He X; Xie J
J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
[TBL] [Abstract][Full Text] [Related]
11. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
12. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
13. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
[TBL] [Abstract][Full Text] [Related]
14. Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM).
Zhang S; Chen K; Zhao Z; Zhang X; Xu L; Liu T; Yu S
J Immunother; 2022 Jul-Aug 01; 45(6):274-283. PubMed ID: 35543550
[TBL] [Abstract][Full Text] [Related]
15. PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM).
Zhang S; Chen K; Liu H; Jing C; Zhang X; Qu C; Yu S
J Immunother; 2021 Jul-Aug 01; 44(6):214-223. PubMed ID: 34028390
[TBL] [Abstract][Full Text] [Related]
16. The role of NLRP3 in the prognosis and immune infiltrates of skin cutaneous melanoma (SKCM).
Wu S; Zang Q; Dai B
Transl Cancer Res; 2021 Apr; 10(4):1692-1702. PubMed ID: 35116494
[TBL] [Abstract][Full Text] [Related]
17. FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma.
Cai Z; Duan Y; Li W; Liu Z; Gong Z; Hong S; He X; Xuanyuan X; Chen Y; Bi X; Wang W
Front Immunol; 2023; 14():1295831. PubMed ID: 38077326
[TBL] [Abstract][Full Text] [Related]
18. HOPX is a tumor-suppressive biomarker that corresponds to T cell infiltration in skin cutaneous melanoma.
He S; Ding Y; Ji Z; Yuan B; Chen J; Ren W
Cancer Cell Int; 2023 Jun; 23(1):122. PubMed ID: 37344870
[TBL] [Abstract][Full Text] [Related]
19. FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma.
Wu S; Liang Y; Zang Q; Xing Z; Yin P; Sun R; Dai B
Appl Bionics Biomech; 2022; 2022():5160748. PubMed ID: 35607429
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
